News
Two former FDA leaders look at Commissioner Marty Makary’s early stumbles — and lay out a list of priorities to protect both ...
The Food and Drug Administration’s (FDA) recent rejection of all study data from Mid-Link Testing highlights the importance of using reliable, ...
The agency could continue to pursue more extensive LDT oversight by tightening control over items like RUO reagents and specimen collection devices.
In another rebuke to federal regulatory overreach, the U.S. District Court for the Eastern District of Texas (“District Court”) has vacated the ...
One attorney said the ruling “isn’t quite the stake in the heart.” The FDA is unlikely to challenge the court’s decision, but ...
The question is not whether AI will transform healthcare; it’s whether regulators can keep pace with that transformation.
The rise of AI in health care presents new challenges related to the patentability and regulation of AI-driven medical ...
On Monday, March 31, a court in the Eastern District of Texas found unlawful and vacated the Food and Drug Administration’s ...
Credit: Saylakham / Shutterstock. The US Food and Drug Administration (FDA) has granted expanded 510(k) clearance for Epitel’s REMI Wireless electroencephalogram (EEG) System for neurological ...
who claims Americans’ food is packed with unsafe ingredients and chemicals—will not affect drug, medical device, or food reviewers or inspectors, HHS said. HHS said the cuts will likely be ...
Once determined to be safe and effective, their clearances open up new regulatory pathways for ... to make updates to previously approved devices. An FDA spokesperson told Fierce Medtech that ...
The reauthorization of FDA’s prescription drug, generics, biosimilar and medical device programs was included in the fiscal 2023 appropriations act, and they are set to expire on Sept.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results